Jakarta - Delayed Quote IDR

PT Millennium Pharmacon International Tbk (SDPC.JK)

140.00 -1.00 (-0.71%)
At close: April 26 at 4:13 PM GMT+7
Key Events
Loading Chart for SDPC.JK
DELL
  • Previous Close 141.00
  • Open 143.00
  • Bid 141.00 x --
  • Ask 139.00 x --
  • Day's Range 139.00 - 144.00
  • 52 Week Range 128.00 - 214.00
  • Volume 713,700
  • Avg. Volume 2,414,779
  • Market Cap (intraday) 178.36B
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) 5.39
  • EPS (TTM) 25.97
  • Earnings Date --
  • Forward Dividend & Yield 2.00 (1.43%)
  • Ex-Dividend Date Jun 7, 2023
  • 1y Target Est --

PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines and medical devices in Indonesia. As of December 31, 2022, it operated 33 branch offices in Java, Bali, Sumatera, Kalimantan, and Sulawesi Islands. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.

www.mpi-indonesia.co.id

1,154

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: SDPC.JK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SDPC.JK
11.39%
IDX COMPOSITE
3.25%

1-Year Return

SDPC.JK
17.87%
IDX COMPOSITE
3.14%

3-Year Return

SDPC.JK
14.98%
IDX COMPOSITE
16.94%

5-Year Return

SDPC.JK
39.16%
IDX COMPOSITE
10.41%

Compare To: SDPC.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SDPC.JK

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    178.36B

  • Enterprise Value

    829.80B

  • Trailing P/E

    5.39

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.05

  • Price/Book (mrq)

    0.64

  • Enterprise Value/Revenue

    0.25

  • Enterprise Value/EBITDA

    6.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.98%

  • Return on Assets (ttm)

    3.81%

  • Return on Equity (ttm)

    12.33%

  • Revenue (ttm)

    3.36T

  • Net Income Avi to Common (ttm)

    33.09B

  • Diluted EPS (ttm)

    25.97

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    58.9B

  • Total Debt/Equity (mrq)

    272.90%

  • Levered Free Cash Flow (ttm)

    -61.88B

Company Insights: SDPC.JK

People Also Watch